From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...

The largest pharmacy-benefit managers hiked the prices of dozens of drugs dispensed through their own pharmacies, according ...

The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...

A report published Tuesday shows hundreds and thousands of percent markups on HIV, hypertension and cancer drugs for Medicare ...

A new FTC report blames Pharmacy Benefit Managers for marking up specialty drug prices, profiting $7.3 billion from cancer and HIV treatments between 2017-2022.

Pharmacy benefit managers make decisions about medication access that aren’t always based on the best interests of patients.

Regulator’s report finds companies ‘hiked costs’ for a range of medicines, including cancer and HIV treatments ...

In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...

A new report by the Federal Trade Commission says pharmacy benefit management companies are driving up your out-of-pocket costs for prescription drugs.

Prescription benefit managers have been under growing scrutiny from state and federal regulators who have accused them of ...

A recognized expert in healthcare technology, Ravi Kottur explores how artificial intelligence (AI) is transforming Pharmacy ...